UK markets closed
NIKKEI 225
27,402.05 +55.17 (+0.20%) HANG SENG
21,958.36 -113.82 (-0.52%) CRUDE OIL
75.89 -0.52 (-0.68%) GOLD FUTURES
1,927.00 -15.80 (-0.81%) DOW
34,053.94 -39.02 (-0.11%) BTC-GBP
19,295.35 -175.12 (-0.90%)
NeuroSense Therapeutics Ltd. (NRSN)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EST
| Previous close | 1.6100 |
| Open | 1.6100 |
| Bid | 1.5700 x 1200 |
| Ask | 1.6400 x 1300 |
| Day's range | 1.6000 - 1.6900 |
| 52-week range | 1.0750 - 8.1800 |
| Volume | |
| Avg. volume | 1,440,463 |
| Market cap | 20.9M |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.6100 |
| Earnings date | 01 Dec 2022 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 7.00 |
- Simply Wall St.
NeuroSense Therapeutics (NASDAQ:NRSN) Is In A Good Position To Deliver On Growth Plans
We can readily understand why investors are attracted to unprofitable companies. For example, although...
- Simply Wall St.
We Think NeuroSense Therapeutics (NASDAQ:NRSN) Can Afford To Drive Business Growth
We can readily understand why investors are attracted to unprofitable companies. For example, although...
© 2023 Yahoo. All rights reserved.
